Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Vanderheyden

Showing results (31-40 of 211) with videos related to

Pageof 22
Sort By:
JACC. Case Reports|July 28, 2021
Progressive Thinning of the Basal Interventricular Septum by Giant Cell MyocarditisArthur Iturriagagoitia, Vanessa Meert, Jeroen De Cocker, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|January 25, 2005
Non-invasive assessment of coronary flow reserve in idiopathic dilated cardiomyopathy: hemodynamic correlationsMarc Vanderheyden, Jozef Bartunek, Sofie Verstreken, et al.
American Heart Journal|January 22, 2005
Oxygen uptake efficiency slope, a new submaximal parameter in evaluating exercise capacity in chronic heart failure patientsChristophe Van Laethem, Jozef Bartunek, Marc Goethals, et al.
Journal of Cardiovascular Translational Research|January 12, 2013
Novel antiplatelet agents: ALX-0081, a Nanobody directed towards von Willebrand factorJozef Bartunek, Emanuele Barbato, Guy Heyndrickx, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2004
Hemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failureMarc Vanderheyden, Jozef Bartunek, Michiel Knaapen, et al.
Heart Failure Reviews|September 14, 2016
Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experienceWard A Heggermont, Marc Goethals, Riet Dierckx, et al.
JACC. Basic to Translational Science|May 4, 2023
Safety, Feasibility of Controllable Decrease of Vena Cava Pressure by Doraya Catheter in Heart FailureRobert Zymliński, Jan Biegus, Marc Vanderheyden, et al.
Current Medical Research and Opinion|December 24, 2019
Impact of increased venous pressure on kidney function and mortality in cardiovascular patients with preserved ejection fractionAnastasios Milkas, Konstantinos Tsioufis, Leonidas Koliastasis, et al.
Journal of Cardiac Failure|August 1, 2014
Activation of the ergoreceptors in cardiac patients with and without heart failureSofie Pardaens, Marc Vanderheyden, Patrick Calders, et al.
Circulation|September 30, 2009
Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgeryMartin Penicka, Hana Linkova, Otto Lang, et al.
Pageof 22

Showing results (31-40 of 211) with videos related to

Sort By:
Pageof 22
JACC. Case Reports|July 28, 2021
Progressive Thinning of the Basal Interventricular Septum by Giant Cell MyocarditisArthur Iturriagagoitia, Vanessa Meert, Jeroen De Cocker, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|January 25, 2005
Non-invasive assessment of coronary flow reserve in idiopathic dilated cardiomyopathy: hemodynamic correlationsMarc Vanderheyden, Jozef Bartunek, Sofie Verstreken, et al.
American Heart Journal|January 22, 2005
Oxygen uptake efficiency slope, a new submaximal parameter in evaluating exercise capacity in chronic heart failure patientsChristophe Van Laethem, Jozef Bartunek, Marc Goethals, et al.
Journal of Cardiovascular Translational Research|January 12, 2013
Novel antiplatelet agents: ALX-0081, a Nanobody directed towards von Willebrand factorJozef Bartunek, Emanuele Barbato, Guy Heyndrickx, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2004
Hemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failureMarc Vanderheyden, Jozef Bartunek, Michiel Knaapen, et al.
Heart Failure Reviews|September 14, 2016
Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experienceWard A Heggermont, Marc Goethals, Riet Dierckx, et al.
JACC. Basic to Translational Science|May 4, 2023
Safety, Feasibility of Controllable Decrease of Vena Cava Pressure by Doraya Catheter in Heart FailureRobert Zymliński, Jan Biegus, Marc Vanderheyden, et al.
Current Medical Research and Opinion|December 24, 2019
Impact of increased venous pressure on kidney function and mortality in cardiovascular patients with preserved ejection fractionAnastasios Milkas, Konstantinos Tsioufis, Leonidas Koliastasis, et al.
Journal of Cardiac Failure|August 1, 2014
Activation of the ergoreceptors in cardiac patients with and without heart failureSofie Pardaens, Marc Vanderheyden, Patrick Calders, et al.
Circulation|September 30, 2009
Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgeryMartin Penicka, Hana Linkova, Otto Lang, et al.
Pageof 22